statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, today announced business updates and financial...

Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results

Pulse Biosciences, Inc. (Nasdaq: PLSE) (Pulse or the Company), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, today announced that the...

Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000

In trading on Monday, shares of Pulse Biosciences Inc (PLSE) crossed below their 200 day moving average of 7.36, changing hands as low as 6.69 per share. Pulse Biosciences Inc shares are...

PLSE Makes Notable Cross Below Critical Moving Average

Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript...

Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Pulse Biosciences just reported results for the fourth quarter of 2023.
The post PLSE Stock Earnings: Pulse Biosciences Reported Results...

PLSE Stock Earnings: Pulse Biosciences Reported Results for Q4 2023

Financial Highlights Reflect Development Progress and Cost ManagementRelated Stocks: PLSE...

Pulse Biosciences Inc (PLSE) Reports Increased GAAP Costs and Narrowed Net Loss in 2023

Pulse Biosciences files for $50M mixed securities shelf...

Pulse Biosciences files for $50M mixed securities shelf

Pulse Biosciences to initiate rights offering...

Pulse Biosciences to initiate rights offering

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

Watchers	1,852
52-Wk Low	$3.78
52-Wk High	$13.62

Volume	233,503.00
52-Wk High	$13.62
52-Wk Low	$3.78

Period	Estimated	Reported	Surprise	Result
Q1'24	--	-$0.14	--	N/A
Q4'23	--	-$0.15	--	N/A
Q3'23	-$0.24	-$0.15	36.73%	BEAT
Q2'23	-$0.24	-$0.22	8.33%	BEAT
Q1'23	-$0.22	-$0.23	-3.02%	MISSED

PLSE Pulse Biosciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals